Eugene W. Gerner - Concepedia

Author

Eugene W. Gerner

Also Known As

C Carf, E Gerner, E W Gerner, E. Gerner, E. W. GERNER, E. W. Gerner, E.W Gerner, E.W. Gerner, EUGENE W. GERNER, Eugene W. Gerner

325

Publications

12K

Citations

H-Index

199

Concepts

All Affiliations

University of Arizona University of California, Irvine Arizona Oncology Arizona Science Center

About

Eugene W. Gerner is an author at University of Arizona specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	95	5.6K
2	Natural Sciences	18	27	1.7K
3	Health Sciences	10	10	454
4	Public Health	7	7	358
5	Engineering	5	5	327

Eugene W. Gerner

160

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial Frank L. Meyskens, Christine E. McLaren, Daniel Pelot, Cancer Prevention Research Sporadic Colorectal AdenomasSurgical OncologyOncologyDifluoromethylornithine Plus SulindacGastrointestinal Oncology	2008	517
Induced thermal resistance in HeLa cells Eugene W. Gerner, Michael J. Schneider Nature Induced Thermal ResistanceMolecular BiologyCell CultureCytoskeletonMedicine	1975	487
Development of difluoromethylornithine (DFMO) as a chemoprevention agent. F. L. Meyskens, Eugene W. Gerner PubMed Medicinal ChemistryChemoprevention StrategyBiochemistryOncogenic AgentMedicine	1999	339
Heat shock proteins in thermotolerance and other cellular processes. Stephen W. Carper, John Duffy, Eugene W. Gerner PubMed Molecular BiologyCytoskeletonProtein RefoldingCellular PhysiologyProtein Expression	1987	222
Clinical hyperthermia: Results of a phase I trial employing hyperthermia alone or in combination with external beam or interstitial radiotherapy Michael R. Manning, Thomas C. Cetas, Robert C. Miller, Cancer	1982	212
Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation Jesse D. Martinez, Elias D. Stratagoules, Janna M. LaRUE, Nutrition and Cancer	1998	205
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene Marı́a Elena Martı́nez, Thomas G. O’Brien, Kimberly E. Fultz, Proceedings of the National Academy of Sciences	2003	195
A transient thermotolerant survival response produced by single thermal doses in HeLa cells. Eugene W. Gerner, Robert Boone, William Connor, PubMed EngineeringCell Inactivation RatesElevated TemperatureThermal TherapyCell Culture	1976	168
Cell cycle-specific activity of type I and type II cyclic adenosine 3':5'-monophosphate-dependent protein kinases in Chinese hamster ovary cells. Maria Inácia Estevão-Costa, Eugene W. Gerner, Diane H. Russell Journal of Biological Chemistry Cell ProliferationCytoskeletonCell CycleType IiCellular Physiology	1976	157
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma Giselle L. Saulnier Sholler, Eugene W. Gerner, Genevieve Bergendahl, PLoS ONE	2015	139

Page 1